DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for Problems Getting an Erection

Information source: Eli Lilly and Company
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Impotence

Intervention: tadalafil (Drug); sildenafil (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Eli Lilly and Company

Official(s) and/or principal investigator(s):
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), Study Director, Affiliation: Eli Lilly and Company

Summary

To determine if men with problems getting and keeping an erection prefer treatment with tadalafil or sildenafil.

Clinical Details

Official title: Switching From Sildenafil Citrate to Tadalafil in Treatment of Erectile Dysfunction: Assessment of Treatment Preference

Study design: Endpoint Classification: Bio-equivalence Study, Intervention Model: Crossover Assignment, Masking: Open Label

Primary outcome: Patient choice of drug at visit 5

Secondary outcome: PAIRS self-administered scale scores

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Male.

Criteria:

Inclusion Criteria:

- History of erection problems

- Anticipate a monogamous female sexual relationship

- Abstain from other erection treatments throughout the study

- Currently use sildenafil

Exclusion Criteria:

- Other primary sexual disorders

- History of radical prostatectomy or other pelvic surgery that affected being able to

have an erection

- History of penile implant or clinically significant penile deformity.

- Nitrate use

- Certain heart problems

Locations and Contacts

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Seoul, Korea, Republic of
Additional Information

Lilly Clinical Trial Registry

Starting date: June 2004
Last updated: October 18, 2007

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017